Monopar Therapeutics·4

Mar 4, 5:25 PM ET

Rodriguez Susan 4

4 · Monopar Therapeutics · Filed Mar 4, 2026

Insider Transaction Report

Form 4
Period: 2026-03-02
Transactions
  • Award

    Stock Options

    [F1]
    2026-03-02+48,72848,728 total
    Exercise: $53.47Exp: 2036-03-02Common Stock (48,728 underlying)
Footnotes (1)
  • [F1]Options vest 6/48ths on September 2, 2026 and 1/48th per month thereafter.
Signature
/s/ Quan Vu, Attorney-in-fact|2026-03-04

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4